CNP-201 in Subjects With Peanut Allergy

NCT05250856 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

15

Enrollment

INDUSTRY

Sponsor class

Stopped Lagging Enrollment and Administrative Reasons

Conditions

Peanut Allergy

Interventions

DRUG: CNP-201
DRUG: Placebo

Sponsor

COUR Pharmaceutical Development Company, Inc.